Drug
Toremifene
Toremifene: highest development phase Phase 3, developed by MeiraGTx. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- MeiraGTx
Trials
| Drug | Phase | Indication |
|---|---|---|
| Toremifene NCT01214291 | Phase 3 | Risk of Bone Fracture Occurrences |
Latest
No recent events.
Follow Toremifene on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.